Sasha King - 07 Jun 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Chief Marketing Officer
Signature
/s/ Peter Maag, as attorney-in-fact for Sasha King
Issuer symbol
CDNA
Transactions as of
07 Jun 2021
Net transactions value
-$564,023
Form type
4
Filing time
08 Jun 2021, 18:37:26 UTC
Previous filing
04 Jun 2021
Next filing
09 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $37,308 +3,048 +6.4% $12.24 50,567 07 Jun 2021 Direct F1
transaction CDNA Common Stock Options Exercise $27,170 +1,000 +2% $27.17 51,567 07 Jun 2021 Direct F1
transaction CDNA Common Stock Options Exercise $97,960 +4,023 +7.8% $24.35 55,590 07 Jun 2021 Direct F1
transaction CDNA Common Stock Sale $726,461 -8,071 -15% $90.01 47,519 07 Jun 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -3,048 -17% $0.000000 14,660 07 Jun 2021 Common Stock 3,048 $12.24 Direct F1, F3
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -1,000 -12% $0.000000 7,333 07 Jun 2021 Common Stock 1,000 $27.17 Direct F1, F4
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -4,023 -25% $0.000000 11,977 07 Jun 2021 Common Stock 4,023 $24.35 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F4 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F5 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.